Idiopathic dilated cardiomyopathy exhibits defective vascularization and vessel formation

Santiago Roura1, Francesc Planas, Cristina Prat-Vidal

  • 1Cardiology Service-Institut Català de Ciencies Cardiovasculars, Hospital Santa Creu i Sant Pau, Barcelona, Spain.

Insights

Idiopathic dilated cardiomyopathy (IDCM) involves abnormal heart vasculature, with shorter, smaller epicardial vessels and reduced microvascular density. This defective vascularization is linked to impaired angiogenesis and vasculogenesis in IDCM patients.

Area of Science:

  • Cardiovascular Research
  • Vascular Biology
  • Regenerative Medicine

Background:

  • Idiopathic dilated cardiomyopathy (IDCM) is characterized by myocyte atrophy and myofilament loss.
  • Vascular abnormalities in IDCM remain poorly understood, despite known cellular changes.

Purpose of the Study:

  • To investigate vascular abnormalities in the epicardium of patients with IDCM.
  • To assess the relationship between vascular changes, hypoxia, and angiogenic regulators in IDCM.

Main Methods:

  • Multi-slice computed tomography (CT) for epicardial vasculature analysis.
  • Endothelial colony formation assay and flow cytometry for endothelial progenitor cells (EPCs) and cytokines.
  • Immunohistochemistry and Western blot for microvessel density and key protein expression (HIF-1alpha, beta-catenin).

Main Results:

  • IDCM hearts exhibited shorter, narrower epicardial coronary arteries and reduced epicardial microvascular density.
  • Epicardial vessel paucity correlated with increased HIF-1alpha positive cells, indicating hypoxia, and elevated VEGF-A.
  • Mobilized CD133+/VEGF-R2+ progenitors were significantly higher in IDCM, alongside reduced myocardial beta-catenin expression.

Conclusions:

  • Human IDCM demonstrates defective vascularization.
  • Impaired vasculogenesis and angiogenesis are key features of IDCM.
  • These vascular defects are associated with altered angiogenic signaling pathways.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...